Neuromonitoring Technologies, Inc. (NMT) is the leading provider of intra-operative, on-site, and EMU/ICU neuromonitoring services. Neuromonitoring Technologies, Inc (NMT) is a privately held company that specializes in on-site EEG services and ICU/EMU neuromonitoring for quick recognition of brain function changes for immediate intervention in the ICU and EMU. NMT also provides Intra-operative Neurological Monitoring (IONM) during surgical procedures that place the central and peripheral nervous system at risk. NMT was founded in 1998 and currently employs 30+ clinical neurophysiologists as well as five board-certified neurologists that, combined, perform over six thousand IONM procedures annually. In 2012 NMT added staff to offer their expertise in neuromonitoring, specializing in continuous EEG monitoring for neurosurgical, pediatric, neonatal, surgical and general medicine ICUs. In 2017, NMT began providing supplemental and primary on-site EEG services to hospitals and neurology clinics. NMT provides IONM services at fifty-four hospitals for over two hundred surgeons throughout the Mid-Atlantic region including Maryland, District of Columbia, Pennsylvania, Virginia, Delaware and New Jersey. Through telemedicine capabilities, NMT has made available their ICU neuromonitoring expertise to ICUs across the country for rapid assessment of brain function. NMT is exploring international telemedicine opportunities providing cEEG in the ICU setting.